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RESUMO 
 
Importantes características são atualmente descritas na periodontite agressiva 
generalizada (PAG): uma agregação familiar dos casos, um perfil microbiológico 
relativamente constante e alterações na resposta inflamatória que levariam a severidade 
nas perdas encontradas. Sendo assim, este trabalho visou avaliar estas três características 
em dois estudos realizados com famílias que apresentavam indivíduos com histórico de 
PAG, comparando-as com famílias com histórico de saúde periodontal. Ambos os estudos 
selecionaram 15 famílias PAG (apresentavam um dos pais com histórico de PAG e pelo 
menos um filho entre 6 e 12 anos) e 15 famílias saúde (ambos os pais apresentavam 
histórico de saúde periodontal e apresentavam pelo menos um filho entre 6 e 12 anos). O 
primeiro estudo visou avaliar as condições microbiológicas das famílias, comparando-as. 
Todos os indivíduos passaram por avaliação clínica dos índices de placa (IP), índice 
gengival (IG) e profundidade de sondagem (PS) além de serem avaliados quanto a 
presença e quantidades totais de Porphyromonas gingivalis (Pg), Tannerella forsythia 
(Tf), e Aggregatibacter actinomycetemcomitans (Aa) no biofilme subgingival por PCR 
quantitativo. Como resultado observou-se uma pior condição clínica das crianças do 
grupo PAG, que apresentaram maiores IP, IG e PS (p≤0,05), situação comparável a 
condição clínica de seus pais. Além disso, maior frequência de detecção e quantidades 
totais de Aa foram observadas nas crianças do grupo PAG (p≤0,05). Pais PAG também 
apresentaram maiores concentrações de Aa e Pg no biofilme subgingival (p≤0,05). 
Ademais, a concentração do Aa em crianças esteve associada com inflamação marginal 
(p≤0,05, r=0,37). O segundo estudo teve como objetivo avaliar o perfil de resposta 
inflamatória das famílias com histórico de PAG. Todas as crianças foram inicialmente 
submetidas a 3 meses de controle de placa antes das avaliações clínicas e inflamatórias. 
Três meses após o início do acompanhamento das crianças, todos indivíduos (pais e 
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filhos) passaram por avaliação clínica do IP, IG, PS, sangramento a sondagem (SS) e 
nível de inserção clínica (NIC) e avaliação dos níveis de IFN-Ȗ, IL-10, IL-17, IL-1ȕ, IL-
4, IL-6, IL-8 e TNF-α no fluído gengival por meio da tecnologia Luminex/MAGpix. 
Crianças apresentaram semelhanças em todos os parâmetros clínicos (p>0,05). Diferença 
nos níveis de citocinas também foi observado e uma maior concentração de IL-10 e IFN-
Ȗ foi percebida em crianças de famílias saudáveis (p≤0,05). Pais GAP apresentaram 
maiores PS e NIC e maiores níveis de IFN-Ȗ, IL-10, IL-17, IL-4, IL-6 foram percebidos 
nos pais do grupo saúde (p≤0,05). Além disso, pais e crianças do grupo PAG 
apresentaram menores razões entre IL10/IL1ȕ e IFN-y/IL4, sugerindo um possível papel 
protetor do IL-10 e IFN-Ȗ nestes indivíduos.  Desta forma, os dois estudos mostraram 
alterações precoces em filhos de indivíduos diagnosticados com periodontite agressiva 
generalizada, sejam elas clínicas, apresentando maiores índices de sangramento, no perfil 
microbiológico, com uma maior concentração de Aa no biofilme subgingival, ou no perfil 
de resposta inflamatória, com uma menor liberação de IL-10 e IFN-Ȗ. 
 
 
Palavras-chave: Periodontite Agressiva. Aggregatibacter actinomycetemcomitans. 
Família. IL-10.  IFN-Ȗ.  
 
 
  
  
ix 
 
ABSTRACT 
Some important characteristics are described in generalized aggressive periodontitis 
(GAP): a familial aggregation of cases, a constant microbiological profile and alterations 
in inflammatory response pattern, leading to a higher severity of disease. In this context, 
the present report aimed to evaluate these characteristics in two different studies accessing 
families with history of GAP and comparing them with families with no history of 
periodontal disease. Both studies selected fifteen GAP families (presenting parent with 
history of GAP and at least one child aged between 6-12 years old) and fifteen healthy 
families (both parents presenting periodontal healthy and at least one child aged between 
6-12 years old). The first study evaluated the microbiological condition of both groups. 
All subjects (parents and children) were assessed for plaque index (PI), gingival index 
(GI), probing depth (PD), besides evaluation of frequency of detection and total amount 
of Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf), e Aggregatibacter 
actinomycetemcomitans (Aa) in subgingival biofilm by qPCR. GAP children showed 
worst clinical conditions, with higher levels of PI, GI and PD, when compared with 
healthy children (p≤0.05). These results were also observed in GAP parents. Higher 
frequency of detection and amount of Aa were observed in GAP children (p≤0.05), while 
GAP parents demonstrated high concentration of Aa and Pg in subgingival biofilm 
(p≤0.05). Furthermore, in spite of adjusted for PI, a significant association between Aa 
amounts and gingival bleeding was observed in children (p≤0.05, r=0.37). The second 
study evaluated the inflammatory response pattern of families with history of GAP. All 
children were included in a strict control of plaque for three months before the clinical 
and inflammatory evaluation. After three months, all subjects (parents and children) were 
assess for PI, GI, PD, bleeding on probing (BoP) and clinical attachment level (CAL) and 
the concentration of   IFN-Ȗ, IL-10, IL-17, IL-1ȕ, IL-4, IL-6, IL-8 and TNF-α in gingival 
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crevicular fluid (GCF) were measured using the multiplexed bead immunoassay 
(Luminex). Low levels of IFN-Ȗ and IL-10 were observed in GCF of GAP children 
(p≤0.05) despite similarities in clinical condition between groups. Higher PD and CAL 
were demonstrated in GAP parents (p≤0.05), while higher levels of  IFN-Ȗ, IL-10, IL-17, 
IL-4, IL-6, were found in healthy parents (p≤0.05). Furthermore, parents and children of 
GAP group presented lower IL10/IL1ȕ and IFN-y/IL4 ratio, suggesting an protective role 
of IL-10 and IFN-Ȗ. Thus, both studies demonstrated initial alterations in children that 
have at least one parent diagnosed with GAP, since clinical changes in bleeding index, 
until changes in microbiological profile (with a higher concentration of Aa in subgingival 
biofilm) and in inflammatory response pattern (with a lower release of IL-10 and IFN-Ȗ).  
 
Key words: Aggressive Periodontitis. Aggregatibacter actinomycetemcomitans. Family. 
IL-10. IFN-Ȗ.   
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INTRODUÇÃO 
 A periodontite agressiva generalizada (PAG) é uma doença inflamatória que acomete 
indivíduos jovens e sistemicamente saudáveis (Armitage, 1999). Quando não tratada, apresenta 
uma progressão rápida, gerando perdas dos tecidos periodontais de suporte e podendo acarretar 
na perda precoce de elementos dentários. A grande severidade da doença faz com que, apesar 
de pouco prevalente na população (0,3 a 3,7% na população jovem brasileira, segundo Susin et 
al, 2014), ela seja alvo de muitos estudos que tentam entender melhor sua etiopatogenia (Page 
& Kornman, 1997; Kinane et al, 2001; Haubek, 2010). Entretanto, apesar de intensamente 
estudada, a incompleta compreensão da população afetada, etiologia, fatores responsáveis pelo 
seu início e progressão trazem dificuldades para se determinar critérios diagnósticos, atividades 
preventivas e a melhor forma de intervenção clínica. 
 Dentre as características mais bem descritas da PAG está a agregação familiar dos casos 
(Meng et al, 2011; Nibali et al, 2008). Seja pela transmissão de características genéticas aos 
seus descendentes, resultando em uma resposta alterada as agressões ou em susceptibilidade à 
doença, ou pelo compartilhamento de fatores de susceptibilidade, sejam eles ambientais, 
comportamentais ou microbiológicos, o acúmulo de casos em uma mesma família tem sido 
amplamente relatado (Meng et al, 2011, Haubek, 2010, Vieira & Albandar, 2014). Sendo assim, 
o estudo em famílias tem se tornado mais frequente, tanto para avaliar possíveis alterações 
genéticas e polimorfismos em genes relacionados a resposta do hospedeiro (Saraiva et al, 2013; 
Andia et al, 2012; Zhong et al, 2012) quanto para avaliar a possível importância de 
microrganismos transmitidos de pais para filhos (Aisikainen et al, 1996) e hábitos de higiene 
(Haubek, 2005).  
 Inicialmente maior importância foi dada ao conhecimento do perfil microbiológico em 
indivíduos com PAG na tentativa de explicar a grande severidade da doença e os diferentes 
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graus de perdas presentes nos indivíduos. Neste contexto, a investigação sobre micro-
organismos mais patogênicos foi intensa e a presença do A. actinomycetemcomitans (Aa) 
(Haubek et al, 2004) e do P. gingivalis (Pg) (Gajardo et al, 2005, Casarin et al, 2010) em 
algumas populações foi amplamente relatada. A transmissão vertical do Aa e do Pg também 
foram descritas (Wilkerhoff & Boutaga, 2005), demonstrando uma possível influência familiar 
no desenvolvimento da doença, entretanto a presença destes micro-organismos também em 
indivíduos saudáveis mostrava que apesar de sua função como fator etiológico, a presença 
bacteriana por si só não foi suficiente para explicar a condição de saúde ou doença. Associado 
a isso, uma cepa mais virulenta do Aa, o clone JP2, foi identificada e mostrou-se altamente 
agressiva aos tecidos do hospedeiro por apresentar forte leucotoxina (Haubek et al, 1996). Esta 
cepa em especial foi associada a perda óssea e progressão da PAG em uma população 
marroquina (Aberg et al, 2014). Entretanto outros estudos não confirmaram a influência do Aa 
no desenvolvimento da PAG e descrevem uma maior complexidade da microbiota interferindo 
na resposta do hospedeiro (Faveri et al, 2008). Sendo assim, muitas controvérsias ainda existem 
quanto às influências de micro-organismos específicos na PAG e qual seria o verdadeiro papel 
do biofilme, apenas causando agressões e provocando uma inflamação local ou causando 
alterações no ambiente subgengival e na resposta do hospedeiro.  
 A ideia vigente atualmente descreve alterações ambientais (dentre elas a presença de 
micro-organismos específicos) e alterações genéticas modulando a resposta do hospedeiro e 
determinando as diferenças na severidade da PAG (Shapira et al, 2005). Desta forma, a 
compreensão dos fenômenos inflamatórios e como eles são alterados tornaram-se de suma 
importância. Sabe-se que a resposta inflamatória nos tecidos periodontais é um mecanismo 
essencial da defesa do organismo (Gemmel et al, 1997). Entretanto, ao mesmo tempo em que 
oferece uma proteção contra o desafio microbiano local, a resposta do hospedeiro provoca a 
degradação das estruturas periodontais adjacentes ao biofilme bacteriano e a perda dos tecidos 
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de suporte dos dentes (Taubman & Kawai, 2001; Cochran et al, 2008). Sendo assim a qualidade 
da resposta inflamatória tem um papel primordial no estabelecimento da doença e na severidade 
que ela irá apresentar (Shaddox et al, 2010). Visando compreender melhor a relação entre as 
destruições periodontais e o padrão de resposta inflamatória característico para a situação de 
saúde e doença, muitos estudos foram realizados e várias citocinas inflamatórias foram 
investigadas para entender sua possível influência no desenvolvimento da PAG. Componentes 
bacterianos foram descritos como estimuladores para a liberação de citocinas, MMPs (matriz 
de metaloproteinase) e fatores de crescimento (Akira et al, 2006)  e a liberação acentuada destes 
produtos está diretamente relacionada com a destruição tecidual (Naguib et al, 2004). 
Analisando indivíduos adultos portadores de PAG altos níveis de IL (interleucina)-1ȕ, IL-2, IL-
4, IL-6, IFN (interferon)-Ȗ e TNF (fator de necrose tumoral)-α foram encontrados por Yue et al 
(2013), alterações em IL-8, IL-1ȕ e TNF-α foram descritos por Ertugrul et al (2013), enquanto 
Casarin et al (2010) observaram menores níveis de IL-10 e menor produção de IgG contra 
patógenos periodontais.  Cairo et al (2010) relataram níveis significativamente maiores de 
citocinas pro inflamatórias (IL-1 ȕ, IL-6, IL-12, TNF-α, IFN-Ȗ) e anti-inflamatórias (IL-4, IL-
1RA, IL-10, IP-10) em indivíduos com PAG quando comparados com indivíduos com saúde, 
gengivite e periodontite crônica. Além disso, mesmo após o tratamento periodontal, elevadas 
concentrações de TNF-α no sangue (Duarte et al, 2010) e IL-1 ȕ no fluído gengival (Toker et 
al, 2010)  ainda puderam ser detectadas. Em crianças portadoras de periodontite agressiva 
localizada, Shaddox et al (2011) relataram quantidades elevadas de citocinas pró-inflamatórias 
como TNFα, INFȖ, IL1ȕ, ILβ, IL6, IL10, no fluido crevicular gengival, enquanto Alfant et al 
(2008) verificaram alterações nos níveis de metaloproteinases. Entretanto, não há na literatura 
estudo que tenha avaliado a liberação de marcadores inflamatórios em crianças oriundas de 
famílias com histórico de periodontite agressiva, sem que a doença tenha se instalado.  
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 Crianças cujos pais apresentam histórico de periodontite agressiva generalizada podem 
ser consideradas como grupo de risco para o desenvolvimento da PAG, uma vez que a 
agregação familiar dos casos já foi descrita e o compartilhamento de fatores de susceptibilidade 
pode ocorrer. Desta forma, uma investigação sobre as condições iniciais destas crianças, 
anteriormente ao desenvolvimento da doença, poderia fornecer informações valiosas sobre 
risco, início e progressão da PAG, e poderiam auxiliar na identificação de indivíduos 
susceptíveis e orientar trabalhos preventivos sobre este grupo. Assim sendo, a presente 
investigação foi feita com o intuito de melhor compreender os aspectos microbiológicos e de 
resposta inflamatória em indivíduos que mesmo não apresentando a doença pudessem 
apresentar previamente alguma alteração. Esta investigação se desenvolveu em dois estudos, 
ambos analisando famílias nas quais pelo menos um dos pais apresentavam PAG e tinham pelo 
menos um filho entre 6 e 12 anos, comparando-as com famílias nas quais ambos os pais eram 
periodontalmente saudáveis e tinham filhos de 6 a 12 anos. O primeiro estudo teve como 
objetivo a avaliação clínica dos indivíduos e das quantidades totais de Porphyromonas 
gingivalis (Pg), Tannerella forsythia (Tf), and Aggregatibacter actinomycetemcomitans (Aa) 
no biofilme subgengival, por meio de qPCR, em pais e filhos, comparando os dois perfis de 
famílias. O segundo estudo, por sua vez, teve como objetivo a avaliação do perfil de liberação 
de citocinas no fluído gengival de pais e filhos, com o uso da tecnologia Luminex MAGPIX, 
comparando os dois perfis de famílias.  
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ABSTRACT 
Aim: Generalized aggressive periodontitis (GAP) is a severe and multifactorial disease in which 
a familial aggregation and a specific microbiological profile has been suggested. Thus, this 
case-control study evaluated the clinical and subgingival microbial profile of GAP subjects and 
their families compared to healthy families. Methods: Fifteen families with parents presenting 
periodontal health and 15 with parents with a history of GAP were selected. Each family should 
have at least one child between 6-12 years old. Plaque index (PI), gingival index (GI), and 
periodontal probing depth (PPD), as well as Porphyromonas gingivalis (Pg), Tannerella 
forsythia (Tf), and Aggregatibacter actinomycetemcomitans (Aa) amounts (by qPCR), were 
assessed from all subjects. Results: Children of GAP families showed worse clinical conditions 
when compared to children of healthy families (p≤0.05).  A higher frequency of detection and 
amounts of Aa was observed in GAP children compared to children of healthy families 
(p≤0.05). Moreover, a significant association between Aa amounts and gingival bleeding was 
observed in children (p≤0.05, r=0.37). Conclusion: Children from GAP families have worst 
clinical conditions, a more pathogenic microbiological profile and the amount of Aa are 
associated with a higher marginal inflammation.  
 
CLINICAL RELEVANCE 
Scientific rationale for study: As the familial aggregation of generalized aggressive 
periodontitis (GAP) is a common observation, children from families in which at least one 
member is affected by disease should be considered as a risk population and the evaluation of 
clinical and microbiological aspects become necessary.    
Principal findings:  Children from families with GAP have worst clinical condition, higher 
frequency of detection and greater amount of Aa. Furthermore, the concentration of Aa was 
associated with marginal inflammation.  
Practical implications: These findings could guide the preventive activities, such as strict 
monitoring and plaque-control, in a higher risk population for GAP development. 
INTRODUCTION 
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Although relatively rare, aggressive periodontitis (AgP) has played a major role in 
periodontal research. However, no clear conclusion regarding its pathogenesis has been drawn 
yet. AgP presents a severe and rapidly progressive destruction of periodontal tissues in 
systemically healthy youngsters, usually from the same familial nuclei (Tonetti & Mombelli  
1999). Susin et al. (2014) reported a prevalence of AgP of 0.1-0.5% in Europe to 1-5% in Africa. 
In Brazil, this disease was detected in 0.3-3.7% of individuals of a young population (Susin et 
al. 2014). Given its rare occurrence and the difficulties in gathering large populations for study, 
our knowledge of AgP is still limited (Shaddox et al. 2012). This hereditary characterization 
has been proven in previous studies; one study even showed an increased risk of GAP 
occurrence in the siblings of affected probands (Nibali et al. 2008). This phenomena probably 
occurs because these individuals share susceptibility factors—genetic and/or environmental—
such as specific oral microbiota.  
Some studies indicate a relatively constant microbiota profile in GAP subjects, in 
contrast to chronic disease, in which Aggregatibacter actinomycetemcomitans (Aa) has been 
suggested as the principal pathogen related to its occurrence and progression (Haubek 2010). 
Other studies, however, have found that P. gingivalis (Pg) is also more prevalent and 
concentrated in AgP (Gajardo et al. 2005; Mayorga-Fayad et al. 2007; Casarin et al. 2010). 
Furthermore, other pathogens (Parvimonas micra and Filifactor alocis) have been recently 
reported as common colonizers in diseased sites of children presenting periodontal destruction 
(Shaddox et al. 2012) and a consortium of bacteria (A. actinomycetemcomitans, S. 
parasanguinis, and F. alocis) was associated with localized aggressive periodontitis and 
indicated future bone loss in specific sites (Fine et al. 2013). In contrast, recent study did not 
confirm the predominance of Aa in GAP patients (Faveri et al. 2008) and, in spite of the efforts 
in determine the importance of each bacteria, the role of specific microorganisms in GAP 
pathogenesis was not completely understood (Kononen & Muller 2014).  
The acquisition of oral pathogens usually occurs by vertical transmission, especially by 
saliva, during childhood (Van Winkelhoff & Boutaga 2005). In relation to Aa, children of Aa-
positive parents presented a higher proportion of positive sites than children in Aa-negative 
parents’ families (Tinoco et al. 1998), indicating a precocious transmission of this pathogen 
within families. Once transmitted, Aa could colonize subgingival areas and, due to its 
pathogenic characteristics, lead to attachment loss (Haubek 2010); thus, it is consider for some 
groups as an attachment loss predictor (Fine et al. 2007; Aberg et al. 2014). In this vein, based 
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on the impact of subgingival microbiota on periodontal status over time, the detection of 
specific bacteria associated with this disease in children at a young age, before disease 
breakdown occurs, would be desirable for the successful prevention and/or treatment of this 
disease (Shaddox et al. 2012). 
Moreover, considering its hereditary pattern, children who the parents have history of 
GAP (GAP children) could be considered a “high-risk” population to develop this disease. 
However, no study has been designed to clinically and microbiologically assess children of 
GAP parents compared to children of periodontally healthy parents, prior to disease 
establishment. Thus, this was the purpose of the present study, hypothesizing that these children 
of GAP families would present dissimilarities in subgingival microbiota when compared to 
children of healthy families, in spite of clinical conditions. 
 
MATERIAL AND METHODS 
 
Study Design 
This study was designed as an age- and gender-matched case-control study trial to assess 
the clinical conditions and subgingival colonization of periodontal pathogens in families 
(parents and children) in which at least one parent has been diagnosed with generalized 
aggressive periodontitis in comparison with families that have periodontally healthy parents. 
The study was approved by the Ethics Committee of the University of Campinas (11/0046) and 
was carried out from 03/2011 until 04/2012.  
 
Population and clinical examination 
Potential study participants were selected from patients referred to the Graduate Clinic 
of Piracicaba Dental School, University of Campinas, Brazil. The study inclusion criteria were 
different for each experimental group:  
- Group Healthy Families (n = 15): Families with both parents (father and mother) 
presenting periodontal health and with at least 1 child (age ranging from 6-12 years 
old). To be considered a periodontally health individual, a subject should not present 
any site with periodontal probing depth (PPD)>4 mm with bleeding on probing 
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(BoP); additionally, the subject must have at least 20 teeth and must be in good 
general health.  
- Group GAP families (n = 15): Families in which at least 1 parent (father and/or 
mother) present the diagnosis of generalized aggressive periodontitis (included in 
supportive periodontal therapy, following the diagnosis criteria previously described 
in Casarin et al. 2010) and at least 1 child (age ranging from 6-12 years old). Each 
GAP subject must have at least 20 teeth, good general health, and age ranging from 
20-35 years of age. 
 
- All children should present permanent 1st molars, either semi- or totally erupted. 
 
The study excluded patients (parents and/or children) who (1) were pregnant or 
lactating, (2) were suffering from any other systemic diseases (cardiovascular, diabetes, or 
other), (3) had received antimicrobials within the previous 3 months, (4) were taking long-term 
anti-inflammatory drugs, (5) had received a course of periodontal treatment within the last 6 
months, or (6) were smokers or former smokers. 
All subjects were clinically assessed by a calibrated examiner (MFM - Intra-class 
correlation=92% of PPD). The clinical parameters evaluated were the following: plaque index 
– PI (Ainamo & Bay 1975), gingival index – GI (Ainamo & Bay 1975), periodontal probing 
depth – PPD (distance of gingival margin to bottom of periodontal pocket/sulcus). Moreover, 
all parents of both groups answered a questionnaire regarding their educational and socio-
economic statuses.  
 
Microbiological Evaluation  
Following the supragingival biofilm removal and relative isolation with cotton rolls, a 
sterile paper point (Nº35) was inserted into the bottom of the periodontal pocket/gingival sulci 
for 30s. The paper points were placed into sterile tubes containing γ00 μL of Tris-EDTA 
0.5mM. Subgingival biofilm samples were collected from mesial and distal of first molars of 
all subjects. In case of the 1st molar’s absence, the βnd molar was elected. All children should 
present permanent 1st molars, either semi- or totally erupted. 
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The presence and concentration of Porphyromonas gingivalis (Pg), Aggregatibacter 
actinomycetemcomitans (Aa), and Tannerella forsythia (Tf) were evaluated using specific 
primers, using a quantitative PCR technique, as reported by Casarin et al. (2012). Briefly, DNA 
was extracted from the subgingival biofilm. A real-time PCR was performed using the FastStart 
DNA Master SYBR Green I kit (Roche Diagnostics GmbH, Mannheim, Germany). The 
concentration of the DNA used in each run was 10 μg/ml. The amplification profiles were 
95°/10`, 55°/5`, 72°/4`, with 40 cycles for Pg; 95°/10`, 55°/5`, 72°/3` and 40 cycles for Aa; and 
95°/10`, 55°/5`, 72°/3`, with 45 cycles for Tf. The determination of the DNA genome copies in 
the controls was based on the genome size of each bacteria and the mean weight of 1 nucleotide 
pair.  
 
Data Management and Statistical Analysis 
The sample size was based on previous studies enrolling microbiological assessments 
in families (Kleinfelder et al. 1999). The results of the clinical data and the total amounts of 
each pathogen were evaluated using a non-paired student’s t test for comparison between GAP 
parents vs. healthy parents and GAP children vs. healthy children. A linear correlation test was 
used for identifying significant relationships between clinical parameters (PI, GI, and PPD) and 
pathogens amounts. All of the analyses were done using the SAS program (release 9.1, 2003, 
SAS Institute Inc, Cary, NC, USA), considering the patient as an experimental unit and α=5%. 
 
RESULTS 
 
Population screening 
 
Figure 1 describe the selection of families. During population screening, 41 GAP 
subjects were examined and interviewed regarding the  age of their children and the exclusion 
criteria. From them, 21 were pre-selected and analyzed regarding the inclusion criteria and 15 
families were selected. After that, 28 healthy parents were screened for the inclusion and 
exclusion criteria and than an evaluation of age and gender distribution of children were made 
to respect the matched design. Fifteen healthy families were selected for participated of the 
study. Thus, 15 “GAP families” and 15 “healthy families” with similar condition were selected.  
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Figure 1. Flow chart of included families 
 
Table 1. Demographic and clinical characteristics of healthy and GAP parents and children 
  
Healthy parents 
(n=26) 
GAP Parents 
(n=26) p 
Age (years±SD) 
 
35.5±2.4 38.1±3.3 0.10* 
Monthly income 
(%) 
Low 29 60 
0.91# Middle 64 40 
High 7 0 
BRL 
(mean±SD) 
3278.6±2147.7 2070.0±894.5 0.12* 
Educational status 
Basic 30% 35% 
0.89# Secondary 52% 59% 
Higher 18% 6% 
Number of sites presenting  
PPD > 4mm and BoP 
0.0±0.0 19.5±6.8 <0.0001* 
 
Healthy 
children  
(n=24) 
Aggressive 
children  
(n=24) 
p 
Age* 8.7±3.2 9.1±4.2 0.73 
Gender# 13 female 13 female 1.00 
*Student’s t test (p<0.05); #Chi-Square test (p<0.05). – SD – Standard deviation; PPD –
Periodontal Probing Depth; BoP – Bleeding on Probing;  
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Table 1 illustrates that no significant differences were observed between the parents in 
healthy and GAP families regarding ages, educational statuses, and  socioeconimic (p>.05). As 
expected, no significant differences between the children of the two groups were seen regarding 
age or gender distribution (p>.05). As also expected, GAP parents presented a higher number 
of sites presenting PPD>4 mm and BoP (p<.0001) than healthy parents.  
 
 
Clinical aspects 
In this study, the clinical parameters evaluated in all subjects were plaque index (PI), 
gingival index (GI), and periodontal probing depth (PPD). As shown in Table 2, statistical 
differences were observed for all parameters when comparisons between healthy parents and 
GAP parents and between healthy children and GAP children were made. GAP children had a 
higher PI (43.1±22.2%), GI (12.0±10.1%), and PPD (2.4±0.4mm) when compared with healthy 
children (24.1±11.1%, 1.7±2.5%, 1.6±0.3mm, respectively) (p<.05). GAP parents also had 
worse clinical conditions than healthy parents (p<.05). 
 
Table 2. Clinical characteristics of Health and GAP parents and health and GAP children.  
  
Health parents 
(n=24) 
GAP parents  
(n=24)  p* 
PI (%) 23.3±15.0 42.7±24.9 0.008 
GI (%) 2.1±2.8 15.6±17.8 0.001 
PPD (mm±SD) 1.9±0.4 2.4±0.5 0.001 
  
Health children 
(n=24) 
GAP children       
(n=24) p* 
PI (%) 24.1±11.1 43.1±22.2 0.001 
GI (%) 1.7±2.5 12.0±10.1 0.0001 
PPD (mm±SD) 1.6±0.3 2.4±0.4 0.04 
*Student’s t test (p<0.05); PI – Plaque Index; GI – Gingival Index; PPD – Periodontal 
Probing Depth; SD – Standard deviation. 
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Microbiological Results 
For the Aa analysis, statistical differences were observed for children and parents in 
comparisons between GAP families and healthy families (Table 3). GAP children presented a 
higher frequency of detection (63.2%) and a superior quantity (1.8±1.5 log[ ]) than healthy 
children ((28.6% and 0.7±0.9 log [ ]), p≤.05).  For parents, a greater amount of Aa in 
comparison to healthy parents (2.9±2.1 and 1.4±1.5 log[ ], respectively (p≤.05)), was noted. P. 
gingivalis was more highly detected and concentrated in GAP parents than healthy ones 
(p<.05), and no differences were observed regarding T. forsythia (p>.05). Tables 4 and 5 
displayed the significant correlation (p≤.05) between Aa amounts and all clinical parameters 
(as well as between them) in children. However, when adjustments were made for the presence 
of plaque, only GI could still be associated to Aa amounts (p≤.05, r=0.37)), rather than PPD 
(p>.05, r=0.20), indicating that there were higher Aa amounts in children, as well as a higher 
gingival index, irrespective of the presence of plaque. 
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Table 3. Frequency of detection and subgingival amounts of periodontal pathogens (mean±SD) 
in health and GAP families. 
 
Frequency Quantification 
% p# log [  ] p* 
A. 
actinomycetemcomitan
s 
Health 
families  Parents 
50.0  1.4±1.5   
 Children 28.6  0.7±0.9  
GAP 
families Parents 
68.2 0.34 2.9±2.1 0.05 
 Children 63.2 0.05 1.8±1.5 0.04 
P. gingivalis 
Health 
families Parents 
30.0  0.9±1.3   
 Children 23.8  0.6±1.1  
GAP 
families Parents 
63.6 0.04 2.8±2.3 0.01 
 Children 52.6 0.1 1.6±1.8 0.11 
T. forsythia 
Health 
families Parents 
65.0  3.5±3.2  
 Children 23.8  1.8±2.7  
GAP 
families Parents 
86.4 0.15 5.4±2.6 0.09 
 Children 52.6 0.1 3.5±3.2 0.07 
#
 Chi-square test and *non-paired Student’s t test for comparison between health and GAP 
parents and Health and GAP children (α=5%). 
 
 
 
 
 
 
 
 
 
 
 
  
15 
 
Table 4. Correlation (r (p value)) between Aa amounts and clinical parameters in GAP and 
Health-children. 
 Aa amounts PI GI PPD 
Aa amounts -  0.61 (0.003) 0.62 (0.002) 0.49 (0.004) 
PI  - 0.66 (<0.0001) 0.59 (0.005) 
GI   - 0.71 (<0.0001) 
PPD    - 
Aa – Aggregatibacter actinomycetemcomitans; PI – Plaque Index; GI – Gingival Index; PPD 
– Periodontal Probing Depth. 
 
 
Table 5. Adjusted r value (PI control) of correlation between Aa amounts and clinical 
parameters in GAP and Health-children. 
Parameters 
GI PPD 
r (p) Adjusted r (p) r (p) Adjusted r (p) 
Aa amounts 0.62 (0.002) 0.37 (0.05) 0.49 (0.004) 0.20 (0.30) 
PI – Plaque Index; Aa – Aggregatibacter actinomycetemcomitans; GI – Gingival Index; PPD 
– Periodontal Probing Depth. 
 
 
 
 
DISCUSSION 
Although the prevalence of AgP is relatively low, and it is apparently confined to 
specific susceptible groups, early stages of this disease could easily be underdiagnosed until 
clear signs of alveolar bone loss are detected in radiographic examination. Therefore, the 
detection of specific bacteria associated with this disease in children at a young age, before 
disease breakdown occurs, could be important for the successful prevention and/or treatment 
of this disease (Shadox et al, 2012), especially considering children of GAP parents. Thus, this 
study assessed children from GAP families and compared them to children of healthy ones, 
showing worst clinical and microbiological conditions in GAP children.  
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Children from families with a history of GAP were selected in the present study once 
they could be considered as having a “higher risk” for developing this disease. The familial 
aggregation is one of the most clear characteristics of aggressive periodontitis (Meng et al. 
2011), result of the shared susceptibilities factor, such as genetic conditions, behavior factors, 
and environmental factors, including a precocious exposure to specific microorganisms (Van 
Winkelhoff & Boutaga 2005). Thus, these children could carry some conditions that could 
facilitate the emergence of the GAP and the initiation of the periodontal breakdown. However, 
to the best of our knowledge, no study has been designed to assess and compare GAP families 
to healthy families, allowing us to identify “pre-disease” aspects of GAP and their potential 
variables.  
As expected, GAP subjects, although in supportive periodontal therapy, presented 
higher amounts and greater frequency of detection of Aa subgingivally when compared with 
healthy parents. Interestingly, children who have one parent diagnosed with GAP also have a 
high frequency of detection and a greater amount of Aa. The results of parents reaffirm the idea 
that Aa could be related to GAP subjects and corroborate with some studies that associated Aa 
with disease and bone loss (Haubek et al. 2004; Cortelli et al, 2005; Casarin et al. 2010). Even 
after active periodontal therapy the presence of Aa could also be described despite a reduction 
in Aa concentration (Kleinfelder et al. 1999). However, although some reports showed the 
presence of Aa in children of localized aggressive periodontitis families (Tinoco et al. 1998), 
this is the first study reporting that children of GAP families presented a similar subgingival 
microbiological pattern of their parents, also prior to GAP establishment, reinforcing the role 
of Aa in this population.  
The major route of acquisition of oral microorganisms is the vertical transmission, and 
saliva is the most common vehicle. Van Winkelhoff and Boutaga (2005), in a literature review, 
estimate the vertical transmission of Aa between 30 and 60% and conclude that if children 
harbor Aa, usually one or two parents harbor the same genotype. A recent study published by 
our group (Monteiro et al. 2014), showed that a child that has a parent colonized by Aa in saliva 
is 16 times more likely to present Aa in his saliva. These results suggest that saliva could be the 
way of contamination of these children by this microorganism, and saliva could be the source 
for subgingival colonization (Asikainen et al. 1997; von Troil-Lindén et al. 1996). Van 
Winkelhoff and Boutaga, in their review, suggest that the proximity of living, the number of 
microorganisms available, and the frequency of contact are important in determining how 
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as necessary for the occurrence of transmission, it is probable that as the amount of 
microorganisms increases, transmission occurs more easily. This, in part, may justify a higher 
presence and quantity of A. actinomycetemcomitans in the children of GAP families because 
these families have parents with a significant, superior concentration of bacteria in the 
subgingival biofilm.  
Once subgingival colonization occurs, A. actinomycetemcomitans could modify the 
environment and the equilibrium between the host and bacteria, causing damage to the 
periodontal tissue and the beginning of the disease (Haubek et al. 2010). This idea could be 
linked to our results that showed a relationship between Aa colonization and gingival bleeding 
in Aa positive-children when adjusted for plaque control. DiRienzo et al. (1994), for example, 
showed a stronger correlation of the presence of Aa and conversion from periodontal health to 
disease. Haubek et al., in sequential studies in a Moroccan population, showed a strict 
relationship between the presence of a specific clone of Aa (JP2_clone) and the progression of 
periodontal attachment loss and the development of aggressive periodontitis (Haubek et al. 
2004; Haubek et al. 2008). The association between Aa presence and periodontal breakdown 
should be due to several virulence factors. Two exotoxins, named leukotoxin and cytolethal 
distending toxin, were described, with leukotoxin considered the major virulence factor of Aa. 
These virulence factors could affect the defense response by modulating cellular activities, the 
release of pro-inflammatory mediators, and the humoral response (Fives-Taylor et al. 1999). 
Thus, even with no confirmation about pathogenic importance of Aa in this study, the presence 
of Aa in the studied children  suggest an association withthe establishment of poor clinical 
conditions and GAP development.  
Meanwhile, it should be highlighted that although A. actinomycetemcomitans have been 
associated with periodontal disease, it could be detected also in healthy subjects. It confirms 
that not only the acquisition but also the persistency of the microorganism (that involve specific 
environmental conditions and susceptibility for colonization) and an inherent host response to 
the pathogen are necessary for disease establishment, which should be assessed in future 
studies. 
Another interesting finding of the present study was the absence of differences in the 
rate of detection and concentration of P. gingivalis in children, in spite of the high detection 
and concentration of P. gingivalis in parents with GAP. P. gingivalis is a strictly anaerobic, 
non-mobile, gram-negative microorganism, and this condition hampers its presence in healthy 
sites as observed in children without signs of the disease, while A. actinomycetemcomitans is a 
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facultative, anaerobic microorganism that could easily live in high levels of oxygen. In this 
vein, the characteristics of A. actinomycetemcomitans may contribute to its identification in 
children and facilitate its colonization in a still healthy environment. Another important fact is 
the predilection of A. actinomycetemcomitans in young subjects. The colonization of the oral 
cavity presumably mainly occurs in the early stages of life, and the colonization with new 
bacterial species⁄clonal types later in life may not occur easily (Haubek β010). Crielaard et al. 
studying the microbiome of children between 3 and 18 years, showed that in these ages, 
microbiota is already in maturation, and the individual is still susceptible to the transmission of 
microorganisms. Moreover, the oral microbiome was shown to be relatively stable, despite the 
significant biological changes that occur during the eruption of teeth (Crielaard et al. 2011). 
Saarela et al. for example, show that children positive for A. actinomycetemcomitans examined 
at the time of their first permanent tooth eruption had the persistence of this bacterium 5-11 
years later and harbored the same strain as they initially did (Saarela et al. 1999). These findings 
suggest that the oral colonization of A. actinomycetemcomitans is stable and becomes 
established at 5-7 years of age. Regarding this, the initial colonization by this microorganism 
in children evaluated in our study is a significant event and might be important to the 
composition of the oral microbiome.  
Surprisingly, besides the higher presence of Aa, children of GAP families also have 
worse clinical conditions when compared with children of healthy families. GAP children have 
worse oral hygiene than healthy children, as observed by a high level of PI (43.1±22.2% and 
24.1±11.1%, respectively), and this condition could lead directly to gingival inflammation and 
a higher probing depth on these children. Moreover, the elevated PI could still contribute with 
the great frequency and quantity of Aa once periodontal pathogens need a complex environment 
to establish themselves, and the existing biofilm may interfere in this colonization. Tinoco et 
al. in 1998, found quite similar results in children of localized aggressive parents. Also, in the 
Brazilian population, the children presented high plaque, gingival bleeding, and Aa 
colonization. However, in this study, no healthy families were included, not allowing a 
comparison or a matched approach (Tinoco et al. 1998). Pahkla et al. in a study that evaluated 
the clinical and microbiological statuses of mothers with chronic periodontitis and their 
children, showed that this group had the worst clinical conditions, poor oral hygiene, and a 
higher rate of detection of periodontal bacteria (including Aa) when compared with healthy 
mothers and their children. They also detect that 71% of children with a diseased mother have 
some alteration in gingiva (gingivitis or periodontitis), while only 15% of kids of healthy 
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mothers have some of these alterations (Pahkla et al. 2010). These results, although in chronic 
periodontitis, are similar with ours and suggest that the periodontal status of parents could 
explain the periodontal condition of their children. In addition, the pattern of hygiene has shown 
a familial standard, and the sharing of susceptibility factors, not only genetic and 
microbiological factors but also behavioral factors (hygiene habits), could interfere with healthy 
periodontal statuses.  
Altogether, the results of the present study bring an opportunity to rethink forms to 
prevent GAP occurrence or to try to detect its establishment prior to periodontal breakdown. 
Considering that these children are members of a high-risk population and have the worst 
clinical and microbiological conditions observed in the present study, they should be included 
in a strict plaque-control regimen and in a long term monitoring. However, future observations 
will provide more information and confirm the validity of this idea. Although no identification 
of specific serotypes/genotypes of Aa has been made (not allowing the vertical transmission 
confirmation), an important association of Aa with GAP and a relationship of this bacteria with 
marginal inflammation in this population was described. Thus, different microbiological 
approaches should be done using an adequate study design (e.g., matching gender and age, as 
done in the present study). Furthermore, recent data indicate that not only microbiological 
aspects are enrolled in GAP pathogenesis, as the host response is also a major player in disease 
occurrence. Therefore, future studies should include immune-inflammatory aspects.   
In conclusion, children who have at least one parent with aggressive periodontitis have 
worst clinical conditions, a higher frequency of detection, and greater amounts of Aa when 
compared to children with both parents with periodontal health. 
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ABSTRACT 
Aim: Generalized aggressive periodontitis still has its etiopathogenesis not fully understood. 
However, many studies have confirmed some alterations in immune-inflammatory patterns, 
even as a familial aggregation. Thus, this study aimed to evaluate the inflammatory pattern of 
children from parents with history of GAP compared to children from healthy parents. Methods: 
Fifteen GAP subjects and their children (6-12 years old) and fifteen healthy subjects and their 
children were selected. The clinical conditions and the local release of cytokines (IFN 
(interferon)-Ȗ, IL (interleukin)-10, IL-17, IL-1ȕ, IL-4, IL-6, IL-8 and TNF (tumor necrosis 
factor)-α) using the multiplexed bead immunoassay (Luminex) were assessed in parents and 
children. Results:  No clinical differences were observed in children when the GAP and healthy 
groups were compared (p>0.05), while differences in PPD and CAL were observed in parents 
(p≤0.05). Dissimilarities in the release of IL-10 and IFN-Ȗ were observed, with GAP children 
presenting lower release of these cytokines (p≤0.05). For parents, GAP ones presented lower 
concentration of IFN-Ȗ, IL-10, IL-4, IL-6 and IL-17 (p≤0.05). IL-10/ IL-1ȕ and IFN-Ȗ/IL-4 
ratios were lower in GAP children and parents when compared to healthy families (p≤0.05).  
Conclusion: Similarities in the response pattern of GAP parents and children could be observed, 
both presenting lower concentration of IL-10 and IFN-Ȗ, as well as IL-10/ IL-1ȕ and IFN-Ȗ/IL-
4 ratios showing that imbalanced host response could be associated to GAP development and 
be presented in descendants. 
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INTRODUCTION 
Generalized aggressive periodontitis (GAP) is a multifactorial disease that affects the 
periodontal tissue of young and systemically healthy subjects (Armitage, 1999). Despite the 
low prevalence (Susin et al, 2014), the complexity in its pathogenesis and the clinical severity 
of GAP draw attention to several researches. Although intensely studied, the lack of information 
about the affected population, etiology, initiation and progression of disease is already an 
impediment to complete comprehension of disease process and to determine diagnosed criteria, 
preventive approaches and the better clinical intervention.  
A very important characteristic of GAP is the familial aggregation of cases (Meng et al, 
2011). Some factors could contribute for the accumulation of cases in the same family, either 
by genetic alteration transmitted for descendants, resulting in altered response pattern to 
aggressions and susceptibility to disease, or by sharing of susceptibilities factors, such as 
environmental, behavioral and microbiological conditions (Haubek, 2010). In this context, 
many studies focused on microbiological pattern of aggressive periodontitis subjects (Mayanagi 
et al, 2004; Faveri et al, 2008) to understand the etiology of GAP and to explain the amount of 
tissue destruction. A constant microbiological profile has been observed in this population, and 
A. actinomycetemcomitans(Aa) and P. gingivalis, in some population, was described as 
important microorganisms (Haubek, 2010; Casarin et al, 2010). However, other studies did not 
observe this relationship (Faveri et al, 2008) and the role of these specific microorganisms in 
pathogenesis of GAP are not totally understood (Kononen & Muller, 2014). Moreover, the 
association with specific microorganisms per se is not sufficient to explain GAP occurrence.  
In spite of incomplete comprehension of specific microorganisms in pathogenesis of 
GAP, it is known that the presence of biofilm is responsible for triggering a cascade of 
inflammatory response (Kulkarni & Kinani, 2014). At the same time that the inflammation is 
responsible for defense against biofilm, the host response in a susceptible subject could cause 
damage to the periodontal tissue and consequently bone loss (Taubman & Kawai, 2001; 
Cochran et al, 2008). In GAP subjects, specifically, an exacerbated inflammatory response is 
observed (Vieira & Albandar, 2014) and probably this condition is the reason of the severity of 
disease. Due to that, many authors have been trying to investigate the relationship of the release 
of inflammatory cytokines with host response to understand the process in which GAP 
develops. Akira et al. (2006) describe that bacterial components could stimulate the release of 
cytokines, MMPs and growth factors and Niguib et al, (2004) associate the high liberation of 
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this products to tissue destruction. However, the evaluation of released cytokines alone is not 
sufficient to complete comprehension of biological aspects involved to inflammatory response 
and to understand the inflammatory pathway, the network of this cytokines, as well as the 
importance of T cells in this process (Garlet, 2010). Specifically for GAP subjects an increased 
release of IL-1ȕ, IL-2, IL-4, IL-6, IFN-Ȗ e TNF-α was identified (Yue et al, 2013), while other 
study show decrease of IL-10 and IgG (Casarin et al, 2010). An altered ratio of IL-10/ IL-1ȕ 
(Teles et al, 2010) and IFN-Ȗ/IL-4 (Schmitd  et al, 2014) were also observed in GAP patient. 
In addition, for children diagnosed with localized aggressive periodontitis, an inflammatory 
evaluation has already been made and elevated level of pro-inflammatory cytokines, such as 
TNFα, INFȖ, IL1ȕ, IL2, IL6, IL10, IL12p40, GM-CSF e MIP1α, were described (Shaddox et 
al, 2011). However, there is no evaluation of the inflammatory response of GAP descendants, 
without clinical sign of disease installation. 
Children from GAP parents (GAP children) could be considered a high-risk population 
for GAP development once familial aggregation is an important characteristic of this disease 
and these children could carry some susceptibility factor for its occurrence. This population has 
already been studied for subgingival colonization and important results of worst clinical 
condition and high colonization by Aa in “GAP children” have been observed (Monteiro et al, 
2014), suggesting that this population could have some other initial alterations. In this vein, the 
screening of this population could provide vital data on the determinants of disease, and more 
information is needed for the establishment of effective health-promotion measures (Susin et 
al, 2014). Thus, get information about inflammatory condition of this group was the purpose of 
the present study, hypothesizing that these “GAP children” would present dissimilarities in 
inflammatory response pattern when compared to “healthy children”. 
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MATERIAL AND METHODS 
 
Study Design 
This study was a case-control study that evaluated the clinical condition and the 
inflammatory response pattern in families with history of GAP (at least one parent has been 
diagnosed with generalized aggressive periodontitis) in comparison with families that have 
periodontally healthy parents. The study was approved by the Ethics Committee of the 
University of Campinas (079/2013) and was carried out from 10/2013 until 11/2014. 
 
Population and clinical examination 
Potential study participants were selected from patients referred to the Graduate Clinic 
of Piracicaba Dental School, University of Campinas, Brazil. The study inclusion criteria were 
different for each experimental group:  
- Group Healthy Families (n=15): Families with both parents (father and mother) 
presenting periodontal health and with at least 1 child (age ranging from 6-12 years 
old). To be considered a periodontally health individual, a subject should not present 
any site with periodontal probing depth (PPD)>4 mm with bleeding on probing 
(BoP); additionally, the subject must have at least 20 teeth and must be in good 
general health. 
 
- Group GAP families (n=15): Families in which at least 1 parent (father and/or 
mother) present the diagnosis of generalized aggressive periodontitis (included in 
supportative periodontal therapy, following the diagnosis criteria previously 
described in Casarin et al. 2010) and at least 1 child (age ranging from 6-12 years 
old). Each GAP subject must have at least 20 teeth, good general health, and age 
ranging from 20-35 years of age. 
 
- All children should have the 1st molar totally or partially erupted.  
The study excluded patients (parents and/or children) who (1) were pregnant or 
lactating, (2) were suffering from any other systemic diseases (cardiovascular, diabetes, or 
other), (3) had received antimicrobials within the previous 3 months, (4) were taking long-term 
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anti-inflammatory drugs, (5) had received a course of periodontal treatment within the last 6 
months, or (6) were smokers or former smokers. 
As demonstrate in figure 1, this study evaluated 62 GAP patients for inclusion and 
exclusion criteria and 23 patients were pre-selected. Of these patients, 6 did not accept start the 
clinical evaluation and β of them didn’t finish the plaque control of children and were excluded. 
Once families of GAP group were selected, the families for control group were assessed from 
Graduate Clinic of Piracicaba Dental School, for inclusion and exclusion criteria and to respect 
the age and gender matched design of the study. Of 16 selected families, one did not finish the 
plaque control and was excluded. There were included in the study 15 GAP families and 15 
healthy families.  
 
Figure 1. Flow chart of included families 
 
All children from GAP and healthy families were included in strict control of plaque 
during three months. Children were evaluated in baseline and received professional control of 
plaque and oral hygiene instruction, procedure that was repeated one month later. Three months 
after the beginning of control of plaque, all children and their parents were assessed for their 
clinical condition and for sample collection.  
All subjects were clinically assessed by a calibrated examiner (MFM - Intra-class 
correlation=92% of PPD). The clinical parameters evaluated were the following: plaque index 
– PI (Ainamo & Bay 1975), gingival index – GI (Ainamo & Bay 1975), periodontal probing 
depth – PPD (distance of gingival margin to bottom of periodontal pocket/sulcus), clinical 
  
30 
 
attachment level – CAL (distance from the cemento-enamel junction to the bottom of 
periodontal pocket/sulcus), bleeding on probing – BoP (Mühlemann & Son, 1971). 
 
Cytokine profile assessment using multiplexed bead immunoassay (Luminex) 
Gingival crevicular fluid (GCF) was collected from 2 incisors and 2 molars of parents 
and children 3 months after the control of plaque of all children by the same examiner (MFM) 
that carried out the clinical evaluation. The collected sites were the ones with the deepest PPD 
of one molar and one incisor of superior arcade and one molar and one incisor of inferior arcade. 
The area was isolated, dried and GCF was collected by placing filter paper strips (Periopaper, 
Oraflow, Plainview, NY, USA) into the pocket until the clinician perceived a slight resistance, 
and then leaving in place for 15 s. The fluid volume was measured with a calibrated device 
(Periotron 8000, Oraflow, Plainview, NY, USA). The strips were placed into sterile tubes 
containing 100 μL of phosphate-buffered saline (PBS) with 0.05% Tween-20. GCF samples 
were immediately stored at -20 °C until multiplexed using a bead immunoassay assay. 
Cytokine levels of interferon (IFN)-Ȗ, interleukin (IL)-10, IL-17, IL-1ȕ, IL-4, IL-6, IL-
8 and tumor necrosis factor (TNF)-α) in GCF were determined using the Sensitivity Human 
Cytokine 08-plex (Millipore Corporation, Billerica, MA). Assays were carried out according to 
the manufacturer’s recommendations using the MAGpix™ instrument (MiraiBio, Alameda, 
CA). The samples were individually analyzed (each pocket separately), and concentrations 
were estimated from the standard curve using a five-parameter polynomial equation using 
Xponent® software (Millipore, Corporation, Billerica, MA). The mean concentration of each 
marker was calculated using the individual as a statistical unit and expressed as pg/ml. 
 
Data Management and Statistical Analysis 
For gender distribution and age, Chi-square and Student’s t tests were used. For all 
clinical data of children and parents (excepted for full mouth parameters in parent), non-paired 
(for groups comparison) and paired (for teeth comparison) Student’s t test were performed. 
Moreover, in Cytokines levels analysis, as well as in parent’s full mouth clinical parameters, in 
order to non-normal distribution (detected in Shappiro-wilk test), Mann-Whitney and Wilcoxon 
non-parametric tests were used for inter and intra-group analysis. All tests considered 
alpha=5%. 
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RESULTS 
 
Population screening 
Table 1 described the demographic condition of GAP and healthy families and the 
number of subjects assessed in this study. No difference in distribution of age and gender of 
parents and children were observed.  
 
Table 1. Demographic characteristics of subjects. 
       
 
n Age p* Gender p* 
Healthy parents 15 36.2±3.6 
0.88 
12 female 
1.0 
GAP Parents 15 36.7±4.2 12 female 
Healthy children 18 9.56±1.98 
0.91 
8 female 
1.0 
GAP children 18 9.72±2.16 8 female 
*Student’s t test for Age and Chi-square for gender, p≤0.05. 
 
 
Clinical aspects 
The clinical conditions of all subjects were demonstrated in table 2 and 3. In table 2, 
GAP parents present a higher PPD, CAL and GMP (p≤0.05). In comparison of clinical 
condition of molars and incisors the only difference was in the GMP value for GAP parents 
(p≤0.05). The clinical conditions of children were described in table γ and no differences could 
be observed in PI, GI, CAL, PPD and Bop in the comparison between groups (p>0.05). 
Differences were observed in GAP children when PPD and CAL of molars and incisors were 
compared (p≤0.05). 
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Table 2. Periodontal parameters in parents from healthy and GAP families 
Wilcoxon test; * Mann-Whitney test. 
 
 
Table 3. Periodontal parameters in children from healthy and GAP families. 
#Wilcoxon test; * Mann-Whitney test. 
 
 
Inflammatory Results 
 Table 4 showed all results of the cytokine levels in GAP and healthy families. 
Interestingly, when division of data from incisors and molars were made, a different pattern of 
response was observed. Regarding to release of cytokines in molars, GAP children showed 
lower levels of IL-10 and IFN-y in GCF (p≤0.05). Also in molars higher concentration of IFN-
y, IL-10, IL-4, IL-6, IL-17 was demonstrated in GCF of healthy parents (p≤0.05). There was 
no difference in release of IL-1ȕ, TNF-α, IL-8 for parents (p>0.05), while for children no 
difference in IL-1ȕ, TNF-α, IL-8, IL-4, IL-6, IL-17 was demonstrate in comparison between 
  
 
PPD CAL GMP PI GI BoP 
Incisor* 
GAP 3.6±0.7 5.1±1.4 1.4±1.4 60.0±33.8 3.6±13.4 50.0±27.7 
Healthy 2.7±0.4 2.7±0.4 0.0±0.0 43.3±37.2 10.0±20.7 43.3±25.8 
p value <0.001 <0.001 <0.001 0.21 0.33 0.51 
Molar* 
GAP 5.1±0.9 5.5±1.0 0.5±0.7 53.3±29.7 17.9±34.4 63.3±39.9 
Healthy 3.4±0.6 3.4±0.6 0.0±0.0 56.7±32.0 16.7±30.9 46.7±35.2 
p value <0.001 <0.001 0.01 0.77 0.92 0.24 
Incisor vs 
Molar# 
GAP (p value) 0.00 0.26 0.02 0.58 0.10 0.33 
Healthy (p 
value) 0.00 0.00 1.00 0.22 0.16 0.75 
 PPD CAL PI GI BoP 
Incisor* 
GAP 2.9±0.6 2.9±0.6 38.9±40.4 13.9±23.0 38.9±36.6 
Healthy 2.8±0.6 2.9±0.6 30.6±34.9 13.9±23.0 25.0±30.9 
p value 0.64 0.78 0.51 1.00 0.23 
Molar* 
GAP 3.3±0.5 3.3±0.5 55.6±48.2 11.1±21.4 55.6±35.0 
Healthy 3.2±0.5 3.2±0.5 52.8±40.1 33.3±42.0 55.6±37.9 
p value 0.28 0.41 0.62 0.16 0.39 
Incisor vs 
Molar# 
GAP (p value) 0.03 0.03 0.27 0.71 0.19 
Healthy (p value) 0.06 0.08 0.09 0.09 0.01 
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groups (p>0.05). The ratio between cytokines was demonstrated in table 5 and higher values of 
IL10/IL1ȕ and IFN-y/IL4 ratio were associated to children and parents of healthy group 
(p≤0.05). The TNF-α /IL-10 ratio was higher for GAP children (p≤0.05), while no difference 
was observed for IL1ȕ /IL4 and INF-y/IL-6 ratio between groups (p>0.05). 
 
 
Table 4. Cytokine profile (pg/mL) in GFC of incisors and 1st molars of parents and children 
from Healthy and GAP families. 
#Wilcoxon test; * Mann-Whitney test. 
 
 
 
 
 
  Parents Children 
  Healthy GAP p* Healthy GAP p* 
IFN-y 
Incisors 16.2±11.4 11.1±14.1 0.32 15.2±9.3 11.6±9.5 0.26 
1st Molars 12.5±11.2 4.0±2.7 0.01 16.2±12.4 9.4±5.7 0.03 
IL-1β Incisors 22.0±11.6 18.0±10.7 0.37 11.6±8.5 15.4±13.8 0.35 1st Molars 31.2±32.3 39.9±48.0 0.59 13.8±8.5 8.1±5.5 0.82 
TNF-α  Incisors 14.3±9.0 13.3±10.5 0.79 15.0±8.9 12.5±5.7 0.33 
1st Molars 8.4±8.4 6.8±6.5 0.58 13.0±12.6 15.1±11.5 0.76 
IL-8 
Incisors 1333.1±978.7 1238.9±1011.0 0.80 1169.4±863.6 1406.5±996.5 0.46 
1st Molars 905.7±762.5 837.3±743.1 0.81 808.3±558.8 709.1±627.6 0.6 
IL-10 
Incisors 23.8±16.8 21.2±19.9 0.71 17.5±8.2 20.9±16.4 0.45 
1st Molars 17.9±12.5 8.0±8.0 0.03 24.0±21.2 14.1±7.5 0.03 
IL-4 
Incisors 16.8±15.5 13.9±15.0 0.60 15.1±9.9 15.0±11.3 0.96 
1st Molars 11.3±10.4 5.2±3.6 0.05 13.0±11.8 7.2±5.0 0.81 
IL-6 
Incisors 19.5±21.8 14.5±12.4 0.46 14.7±9.0 18.0±9.8 0.29 
1st Molars 11.7±9.3 5.9±4.4 0.05 18.0±17.0 13.3±11.2 0.57 
IL-17 
Incisors 10.6±7.5 6.6±6.6 0.16 10.5±9.0 8.4±6.5 0.43 
1st Molars 7.1±7.4 2.8±1,6 0.04 10.3±9.5 5.7±4.3 0.54 
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Table 5. Ratio of cytokines concentration of parents and children from Healthy and GAP 
families. 
 
 
IL-10/IL-1β IFN-y/IL4 IL-1β/IL-4 TNF-α/IL-10 IFN-y/IL-6 
Children 
GAP 1.2±0.7 0.7±0.2 1.2±0.8 1.1±0.7 1.1±0.5 
Healthy 1.8±1.0 1.3±0.5 1.3±0.9 0.6±0.3 1.3±0.6 
p value 0.04 <0.001 0.7 0.008 0.28 
Parents 
GAP 0.4±0.4 0.8±0.2 10.4±12.9 0.8±0.4 0.9±0.6 
Healthy 1.5±1.5 1.2±0.5 5.3±10.0 0.6±0.4 1.2±0.7 
p valeu 0.046 0.006 0.28 0.21 0.25 
#Wilcoxon test; * Mann-Whitney test. 
 
 
DISCUSSION 
 Based on familial aggregation, children of GAP parents could be considered a higher 
risk population for GAP development. Moreover, the association of an altered inflammatory 
response and GAP etiology suggests that these children could demonstrate some inflammatory 
alteration, prior to disease installation. Thus, the purpose of this study was to investigate the 
inflammatory condition of children from GAP families and compare them to children whose 
both parents are periodontally healthy. Despite similarities in all clinical parameters (PI, GI, 
PPD, BoP), children of GAP parents showed a different pattern of released cytokines. For GAP 
parents, in spite of supportive periodontal treatment of all subjects, an expected alteration in PD 
and CAL and an altered cytokine profile could be noted.  
 The study of families in GAP is an important tool to understand specific characteristics 
of initiation and progression of disease once familial aggregation is a described trait of GAP 
(Meng et al, 2011; Nibali et al, 2008) and the selection of a possibly susceptible group could 
facilitate the observation of initial events prior to disease establishment. In this context, many 
studies focus on microbiological condition of GAP patients, and A. actinomycetemcomitans 
(Aa) assume a prominent role (Haubek, 2010). Specifically for children from GAP families, the 
association of Aa and marginal inflammation could be observed in another study. Interestingly, 
GAP children also showed a poorer oral hygiene, indicating that this population also presents a 
negative behavior to plaque control (Monteiro et al, 2014). In the present study, after a plaque 
control program, PI, as well as GI, PPD and BoP, of GAP children were similar to those of 
healthy children, allowing an unbiased immunological profile comparison. 
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 In the present study, GAP and Healthy parents showed dissimilarities in release of GCF 
cytokines. A lower release of IFN-Ȗ, IL-10, IL-17, IL-4, and IL-6 was observed in GAP and no 
differences were observed for IL-1ȕ, IL-8, and TNF-α. In respect of IL-1ȕ concentration, an 
apparently contradictory result was observed, since it is an important pro-inflammatory 
cytokine highly released in inflammation, a potent stimulator of bone resorption (Graves & 
Cochran, 2003), commonly observed in higher concentration in GAP patients (Teles et al, 2010, 
Toker et al, 2008). Other pro-inflammatory cytokines in which higher concentration would be 
expected in GAP patients, such as TNF-α, IFN-Ȗ and IL-6, also didn’t demonstrate this 
condition. However, it should be remembered that all GAP patients were prior treated and were 
included in periodontal supportive therapy. 
 Interestingly, despite the similar clinical condition of children from both groups, GAP 
children demonstrated a different cytokine profile pattern of healthy children. A lower release 
of IL-10 and IFN-Ȗ and decreased IFN-Ȗ/IL-4 and the IL-10/IL-1ȕ ratio were observed in GAP 
children. Moreover, the same differences were also described in GAP parents, suggesting that 
a similar response pattern could be associated to a familial component of disease. However, in 
spite of an altered inflammatory pattern was described in GAP, it should be highlighted that the 
role of specific cytokines, the network between them and their associations in host response, 
are not completely understood (Vieira & Albandar, 2014). Thus, the comprehension of the 
global aspects of inflammatory response and the pathways in which cytokines act became 
necessary to understand the disease process.  
 Cytokines can be functionally grouped as Th (helper) 1, Th2, Th17 and T regulatory 
(Treg) based on their expression pattern and effects on target cells or tissues. IFN-Ȗ is the 
signature cytokine of Th1-type responses, being considered the main phagocyte-activating 
cytokine and being important for the activation of cell-mediated immunity to control intra-
cellular pathogens and autoimmunity. IL-4, IL-5, IL-13 and IL-25 are Th2 cytokines which 
drive humoral immunity to control extracellular parasites and also have been involved in B cell 
activation. The Th17 cytokines are IL-1ȕ, IL-6, IL-21, IL-22, IL-23 and IL-17 that enhance an 
immune response against extracellular bacteria and lead to an inflammatory condition. TGFȕ, 
IL-2 and IL-10 are considered as Treg cytokines that are important to maintain a balanced 
immune response through negative regulation of other T-helper responses (Mucida & 
Cheroutre, 2010; Garlet et al, 2010; Ebersole et al, 2014). In spite of the suggested function of 
T cells in periodontal tissue, the role of T-helper 1 cells and T-helper 2 cells, as well as the 
importance of different pro-inflammatory and anti-inflammatory cytokines, is still unclear 
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(Kulkarni & Kinani, 2014). A suggested explanation for periodontal disease and the progression 
of bone loss proposed that non-susceptibility to periodontitis involves IL-2 and IFN-Ȗ-
producing Th1 cells that induce a delayed-type hypersensitivity response, synonymous with the 
putative T-cell stable lesion. In contrast, susceptibility to periodontitis is promoted by IL-4-
producing Th2 cells, providing B-cell activation and production of non-responsive antibodies 
associated to tissue destruction. (Seymour et al, 1979; Gemmel & Seymour, 2004; Gemmel et 
al, 2007). However, the dominance of B cells and plasma cells in periodontal lesions cannot 
totally be explained by a higher Th2 functions but probably by an imbalance in dynamic of all 
T cells (Berlung et al, 2005). 
In the present study, the IFN-Ȗ/IL-4 and the IL-10/IL-1ȕ ratio demonstrate the balance 
of T cells products and the evaluation of Th1/Th2 and Treg/Th17 ratios in parents and children 
from GAP and healthy families. Parents and children of GAP group demonstrate lower ratio in 
both cases, suggesting that an imbalance were observed in these subjects with decrease in Th1 
and Treg function and/or enhance in Th2 and Th17 function. In this vein, these results 
corroborate to the literature that demonstrate the same imbalance for GAP subjects in IL-10/IL-
1ȕ ratios ratio (Teles et al, 2010) and IFN-Ȗ/IL-4 ratio (Schimitd et al, 2014). The classical IFN-
Ȗ/IL-4 ratio, support the idea that subjects with GAP have higher function of Th2 route and this 
condition lead to activation of B cells and tissue destruction. Interestingly, despite the 
association of IFN-Ȗ to pro-inflammatory function, related to high levels in progressive lesions 
or higher-severity periodontal disease forms (Garlet et al, 2003; Honda et al, 2006; Dutzan et 
al, 2009), IFN-Ȗ is also highly expressed by cells of healthy controls (Gonzales et al, 2012;) as 
demonstrated in the present study. This find is consistent with the early immune-regulatory role 
of this cytokine, necessary for the immediate response with high IFN-Ȗ secretion to immature 
antigen-presenting cells (Gonzales et al, 2012). Thus, IFN-Ȗ plays an essential role in control 
of infections, acting in phagocyte-activating cytokine by enhancing phagocytosis and 
stimulating the production of inflammatory cytokines, chemokines, and microbicidal molecules 
(Schroder et al, 2004). In this vein, the lower concentration of this cytokine in GAP children, 
as well as the IFN-Ȗ/IL-4 ratio, could be associated to a destructive profile and susceptibility to 
disease development. There was also suggested that equilibrium of Th1/Th2 pathway is 
associated to health and protection, and when the Treg/Th17 pathway is activate, this two routes 
acting in periodontal destruction (Ebersole et al, 2014).  
Emerging evidence indicates that the recently described Th17 cytokines response 
appears to play a critical role in periodontitis and their activation was associated to progression 
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of periodontal lesions (Cardoso et al. 2009, Adibrad et al. 2012), while the regulated function 
of Treg is related to control of inflammation. Thus, the IL-10/IL-1ȕ evaluation has been useful 
for better comprehension of damage process and aggressive periodontitis (Teles et al, 2010; 
Toker et al, 2008). In the present study, the IL-10/IL-1ȕ ratio showed to be lower in GAP 
parents and children, suggesting that an imbalance in the Treg/Th17 may lead to a lower 
function of Treg and/or a higher function of Th17 pathway. As mentioned, IL-1ȕ is a cytokine 
commonly found in GCF of GAP patients and is related to initial aspects of inflammation and 
bone loss. Ebersole et al, studying the initiation, progression and remission of periodontal lesion 
in an animal model, described that high levels of IL-1ȕ, were involved to acute phase of 
periodontal destruction and that these cytokines were fundamental to activation and 
maintenance of Th17 pathway. However, in a condition of no disease or remission of disease 
the IL-1ȕ levels seem to be lower and stable (Ebersole et al, 2014). This could in part be 
associated to the present result once no difference in IL-1ȕ concentration between groups was 
observed and the subjects had no clinical sign of bone loss or they were treated for GAP, 
suggesting that an under activation of Th17 could be presented. On the other hand, a higher 
concentration of IL-10 was demonstrated in GCF of healthy group, suggesting a higher 
activation of Treg route. IL-10 is a potent anti-inflammatory cytokine commonly found in 
higher concentration in healthy sites when compared to GAP sites. Although expressed in both 
healthy and inflamed human periodontal tissues, the lack of IL-10 was linked to accelerated 
alveolar bone loss (Al-Rasheed et al, 2003) and low levels of its expression is associated to 
GAP (Garlet et al, 2003). It is suggest that IL-10 might be involved in controlling the 
inflammatory process at periodontally healthy sites (Teles et al, 2010), thus, IL-10 can be a 
protective cytokine in periodontal diseases and regulates pro-inflammatory cytokines, including 
those implicated in alveolar bone loss (Hirose et al 2001). Then, a reduction of IL-10 levels in 
GAP parents and their children could be important to hamper an efficient clearance or 
management of pathogenic biofilm by immune cells and ultimately interfere in periodontitis, 
while a fine-tuned balance in the IL-10 levels in healthy subjects seem to be critical to remove 
efficiently pathogens without causing pathology and maintain an equilibrated Treg function. 
In this case, IL-10 and IFN-Ȗ could have a protective function in periodontal tissue of 
healthy subjects and the lower ratio of the purposed cytokines in GAP subjects could be related 
to susceptibility and progression of disease. The periodontal tissue from patients may be 
continually exposed to microbiological challenge that could stimulate an immune response 
resulting in subclinical inflammation that is not detected by the available methods for clinical 
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diagnosis (Armitage, 1996). This fact reinforces the hypothesis that the commonly used clinical 
diagnostic procedures cannot reliably identify sites or subjects with ongoing periodontal 
destruction and, therefore, biochemical markers such as cytokines may be useful to assess the 
subclinical inflammatory process (Armitage, 1996). Specifically for the studied children, 
descendants of GAP patients, considered a high risk population for GAP development, this 
condition was observed. In spite of no clinical difference in relation to “healthy children” could 
be noted, differences in cytokine release (decrease IL-10 and IFN-Ȗ) and in the balance in Tcells 
pathways (tendency to higher function of Th2 and Th17) were found in GAP children and they 
were apparently similar to parents pattern.  
In respect to that, the use of laboratory tool for assesses the ratio of specific cytokines 
in a higher risk group could be useful to precocious diagnoses and identification of susceptible 
group.  Although interesting results were found, the association of pattern of released cytokines 
and GAP progression has to be confirmed by longitudinal studies. Once confirmed the 
relationship of reduction of specific cytokines expression and GAP more studies should be 
proposed to assess genetic alterations associated to this condition and to comprehend the 
biological process involved on that. Furthermore, studies of cytokine changes over time have 
to be considered to get information about initiation and progression of the disease, being useful 
to identify the prognosis of early lesions and susceptible individuals.  
 Thus, in spite of the limitations of this work, important information about differences in 
initial response of a “high risk” group was obtained. The better comprehension of initial aspects 
of GAP may guide the preventive actions; important characteristics of disease initiation could 
be used as a predictor and could help the screening and monitoring of a risk group for GAP 
development. In conclusion, lower release of IL-10 and IFN-Ȗ and a decreased IFN-Ȗ/IL-4 and 
the IL-10/IL-1ȕ ratio was observed in children and parents of GAP families when compared to 
healthy families, suggesting that this cytokines could have a protective role in healthy patients  
and that the reduction level of this cytokines in children from GAP families could be related to 
initiation of disease.  
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CONCLUSÃO 
Crianças que apresentam pelo menos um dos pais com histórico de periodontite 
agressiva apresentam piores condições clínicas (maiores índice de placa, índice gengival e 
profundidade de sondagem), maior frequência de detecção e maiores concentrações de Aa no 
biofilme subgengival. Além disso, quando um ajuste para o índice da placa foi feito, a 
concentração do Aa mostrou associação positiva com o sangramento marginal das crianças.  
Quando controle de placa foi realizado nas crianças, uma condição clínica semelhante 
foi observada entre os grupos saúde e PAG. As crianças PAG apresentaram menor liberação de 
IL-10 e IFN-Ȗ no fluído gengival, enquanto os pais PAG apresentaram menor liberação de 
IFNy, IL-10, IL-4, IL-6, IL-17. Além disso, pais e crianças do grupo PAG apresentaram 
menores razões entre IL10/IL1ȕ e IFN-y/IL4, sugerindo um possível papel protetor do IL-10 e 
IFN-Ȗ nestes indivíduos. 
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